teladoc health reported a larger-than-expected financial loss in Q4, leading to a drop in their stock price. The company also provided disappointing future revenue guidance and announced an acquisition of catapult health.

reported a wider loss than analysts expected and issued disappointing quarterly guidance.

CEO of Teladoc expressed the company's focus on growth opportunities.

Teladoc acquired livongo in 2020, which had a combined enterprise value of $37 billion.

Teladoc announced its acquisition of catapult health for $65 million.